Lumen Technologies, Inc.
Lumen Technologies, Inc. (LUMN) Financial Performance & Income Statement Overview
Analyze Lumen Technologies, Inc. (LUMN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Lumen Technologies, Inc. (LUMN) Income Statement & Financial Overview
View the income breakdown for Lumen Technologies, Inc. LUMN across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.18B | $3.33B | $3.22B | $3.27B |
| Cost of Revenue | $1.69B | $1.71B | $1.69B | $2.40B |
| Gross Profit | $1.50B | $1.62B | $1.53B | $872.00M |
| Gross Profit Ratio | $0.47 | $0.49 | $0.47 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $675.00M | $749.00M | $696.00M | $742.00M |
| Operating Expenses | $1.39B | $1.47B | $1.40B | $742.00M |
| Total Costs & Expenses | $3.08B | $3.17B | $3.10B | $3.14B |
| Interest Income | $0.00 | $29.00M | $18.00M | $14.00M |
| Interest Expense | $0.00 | $357.00M | $351.00M | $373.00M |
| Depreciation & Amortization | $713.00M | $758.00M | $707.00M | $743.00M |
| EBITDA | $815.00M | $996.00M | $886.00M | $1.07B |
| EBITDA Ratio | $0.26 | $0.30 | $0.28 | $0.33 |
| Operating Income | $107.00M | $154.00M | $126.00M | $130.00M |
| Operating Income Ratio | $0.03 | $0.05 | $0.04 | $0.04 |
| Other Income/Expenses (Net) | -$352.00M | -$273.00M | -$298.00M | -$171.00M |
| Income Before Tax | -$245.00M | -$119.00M | -$172.00M | -$41.00M |
| Income Before Tax Ratio | -$0.08 | -$0.04 | -$0.05 | -$0.01 |
| Income Tax Expense | -$44.00M | -$204.00M | -$24.00M | $8.00M |
| Net Income | -$201.00M | $85.00M | -$148.00M | -$49.00M |
| Net Income Ratio | -$0.06 | $0.03 | -$0.05 | -$0.01 |
| EPS | -$0.20 | $0.09 | -$0.15 | -$0.05 |
| Diluted EPS | -$0.20 | $0.09 | -$0.15 | -$0.05 |
| Weighted Avg Shares Outstanding | $991.27M | $987.68M | $988.79M | $987.24M |
| Weighted Avg Shares Outstanding (Diluted) | $991.27M | $987.68M | $988.79M | $987.24M |
The company's financials show resilient growth, with revenue advancing from $3.27B in Q2 2024 to $3.18B in Q1 2025. Gross profit remained healthy with margins at 47% in Q1 2025 compared to 27% in Q2 2024. Operating income hit $107.00M last quarter, sustaining a consistent 3% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $815.00M. Net income dropped to -$201.00M, while earnings per share reached -$0.20. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan